Fig. 5 | Scientific Reports

Fig. 5

From: Comprehensive analysis of Mendelian randomization and scRNA-seq identify key prognostic genes and relevant functional roles in colorectal cancer

Fig. 5

Analysis of drug sensitivity and prognosis prediction in CRC patients. (A) Nomogram for predicting the prognosis of CRC. (B) Calibration curve for survival rate prediction in CRC patients. The nomogram-predicted overall survival (OS) is on the x-axis, with the observed OS on the y-axis. (C) ROC curve of MMRN1 for predicting the onset and progression of CRC. The peak ROC value was 0.974 (95% CI, 0.962–0.986). (D) ROC curve of SLC6A19 for predicting the onset and progression of CRC. The peak ROC value was 0.953 (95% CI, 0.929–0.977). (E) Analysis of MMRN1 sensitivity to common chemotherapy drugs. (F) Analysis of SLC6A19 sensitivity to common chemotherapy drugs.

Back to article page